Analysis of the residual tumor masses in the above study revealed that the surviving cancer cells were all CD19 negative, suggesting that the absence of completes responses was largely due to loss or downregulation of the mCD19 “tumor antigen” (Figure S2). The gene discussed is LINC01194; the disease is cancer.